Related Experiment Video
Updated: Oct 12, 2025

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Prevalence of occult hepatitis C virus infection in hemodialysis patients
Masomeh Bayani1, Mohammad Reza Hasanjani Roushan1, Mohammad Jafar Soleimani Amiri1
1Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Insights
Occult hepatitis C infection (OCI) affects hemodialysis patients, with prevalence linked to longer dialysis duration. This study found OCI in 2.65% of patients, highlighting transmission risks in dialysis settings.
Area of Science:
- Hepatology
- Infectious Diseases
- Nephrology
Background:
- Hemodialysis patients are at risk of viral infections, including occult hepatitis C virus (HCV) infection (OCI).
- OCI is defined by the presence of HCV in tissues like the liver and PBMCs, despite negative serum tests and normal liver enzymes.
- Understanding OCI prevalence in hemodialysis patients is crucial for infection control.
Purpose of the Study:
- To determine the prevalence of occult hepatitis C infection (OCI) in patients undergoing hemodialysis.
- To investigate potential associations between OCI and factors such as age, sex, and duration of dialysis.
Main Methods:
- A cross-sectional study was conducted on 302 hemodialysis patients in Mazandaran province, Iran (2012-2014).
- Serum and peripheral blood mononuclear cells (PBMCs) were tested for HCV RNA using real-time PCR.
- Patients with positive HCV antibodies were excluded prior to enrollment.
Main Results:
- Eight patients (2.65%) were diagnosed with occult hepatitis C infection (OCI).
- A significant association was found between the duration of hemodialysis and the prevalence of OCI (P=0.017).
- No significant association was observed between OCI and patient age or sex.
Conclusions:
- The prevalence of occult hepatitis C infection (OCI) in hemodialysis patients was found to be 2.65%.
- Longer duration of dialysis is a significant risk factor for developing OCI in this population.
- These findings underscore the importance of vigilant screening and infection control measures in hemodialysis units.
Background:
Via hemodialysis, viral infections can be transmitted in patients a new definition of this infection with no increase in liver enzymes, negative HCV-PCR in serum and presence of virus in the liver and peripheral blood mononuclear cell (PBMC) called occult hepatitis C virus (HCV) infection (OCI). We decided to examine the prevalence of occult hepatitis C infection on hemodialysis cases.
Methods:
The current research is a cross-sectional study on patients with end-stage renal disease (ESRD) who were at three hemodialysis centers in Mazandaran province in Iran during 2012-2014. In this study of 356 patients who were undergoing hemodialysis, 54 patients were excluded due to positive HCV Ab, and the remaining 302 patients were enrolled. The test of all serum samples for HCV-RNA detection of plasma and PBMCs was done by real-time polymerase chain reaction (real-time PCR).
Results:
There was a significant association between the duration of dialysis with the prevalence of occult HCV infection (P=0.017). Eight (2.65%) patients were positive for HBs Ag and with OCI, but none of them was infected with both hepatitis C and B obviously. Also among the total number of patients, nine patients tested positive for HCV RT-PCR in PBMC in which one of them was positive for serum HCV RNA PCR and was excluded from the study.
Conclusion:
The results showed that eight patients had an OCI. There was not any association found between age and sex with OCI, but there was a significant relationship between the duration of dialysis with the prevalence of OCI.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

